Jul 3 |
Caribou Biosciences: Promising Gene Editing Therapies With Strong Buy Potential
|
Jun 4 |
Cracking The Code: Understanding Analyst Reviews For Caribou Biosciences
|
Jun 3 |
Top Midday Decliners
|
Jun 3 |
Caribou stock plunges 30% amid study update, Evercore downgrade
|
Jun 2 |
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
May 30 |
Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences
|
May 16 |
Expert Ratings For Caribou Biosciences
|
May 9 |
Caribou Biosciences, Inc. (NASDAQ:CRBU) Analysts Are Cutting Their Estimates: Here's What You Need To Know
|
May 7 |
Caribou Bioscience GAAP EPS of -$0.46 misses by $0.05, revenue of $2.43M beats by $0.01M
|
May 7 |
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
|